Abstract:Yellow fever (YF), a mosquito-borne viral hemorrhagic fever, is endemic in Uganda and causes frequent outbreaks. A total of 1.6 million people were vaccinated during emergency mass immunization campaigns in 2011 and 2016. This study explored local perceptions of YF emergency mass immunization among vulnerable groups to inform future vaccination campaigns. In this qualitative study, we conducted 43 semi-structured interviews, 4 focus group discussions, and 10 expert interviews with 76 participants. Data were collected in six affected districts with emergency mass vaccination. We included vulnerable groups (people ≥ 65 years and pregnant women) who are typically excluded from YF vaccination except during mass immunization. Data analysis was conducted using grounded theory. Inductive coding was utilized, progressing through open, axial, and selective coding. Participants relied on community sources for information about the YF mass vaccination. Information was disseminated door-to-door, in community spaces, during religious gatherings, and on the radio. However, most respondents had no knowledge of the vaccine, and it was unclear to them whether a booster dose was required. In addition, the simultaneous presidential election during the mass vaccination campaign led to suspicion and resistance to vaccination. The lack of reliable and trustworthy information and the politicization of vaccination campaigns reinforced mistrust of YF vaccines. People in remote areas affected by YF outbreaks rely on community sources of information. We therefore recommend improving health education, communication, and engagement through respected and trusted community members. Vaccination campaigns can never be seen as detached from political systems and power relations. Yellow fever is transmitted by mosquitoes in tropical regions of South America and Africa. It can cause severe illness and death. Yellow fever can be prevented with a vaccine. However, people in several affected regions are not vaccinated because the vaccine is expensive and not part of routine immunization. For them, access to the vaccine is only possible during emergency mass vaccination campaigns when an outbreak occurs. In this study, we explored local perceptions of emergency yellow fever mass vaccination among vulnerable groups (people over 65 years and pregnant women) in Uganda to understand better how these people have access to vaccine information, what information reaches affected communities, what motivates people to be vaccinated, and what political motives may influence vaccination programs. Despite extensive campaigns, we found that the information reaching communities varied widely, with people relying heavily on community sources. In addition, the lack of trustworthy information and the politicization of vaccination campaigns increased mistrust of yellow fever vaccines. We also found that informed consent is only possible if the principle of vaccination—protection from disease—is understood. Awareness campaigns should focus on a broad understanding of the importance of immunization. Those involved in organizing campaigns should be aware of the potential impact of politicization on vaccine uptake.

High confidence and demand for hepatitis E vaccine during an outbreak in Bentiu, South Sudan: A qualitative study

Vaccination coverage and adverse events following a reactive vaccination campaign against hepatitis E in Bentiu displaced persons camp, South Sudan

Safety of hepatitis E vaccine in pregnancy: an emulated target trial following a mass reactive vaccination campaign in Bentiu internally displaced persons camp, South Sudan

The 2023 South Sudanese outbreak of Hepatitis E emphasizes ongoing circulation of genotype 1 in North, Central, and East Africa

HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh

Raising the case of hepatitis E: Report from the 2nd international HEV symposium

Hepatitis E Vaccine To Prevent Morbidity And Mortality During Epidemics

Prevalence and factors associated with hepatitis b vaccination uptake and completion among communities targeted for mass vaccination in gulu: a cross-sectional study

Progress and Challenges to Hepatitis E Vaccine Development and Deployment

Hepatitis E vaccine in China: Public health professional perspectives on vaccine promotion and strategies for control

First hepatitis E outbreak in Southeastern Senegal

Perceptions of yellow fever emergency mass vaccinations among vulnerable groups in Uganda: A qualitative study

Hepatitis B serology testing and vaccination for Gambian healthcare workers: A pilot study

Knowledge, attitudes, and practices and long-term immune response after rVSVΔG-ZEBOV-GP Ebola vaccination in healthcare workers in high-risk districts in Uganda

Long-Term Hepatitis B Vaccine Immunity in Ethiopian Children That Received a Pentavalent Vaccine Series: A Retrospective Cohort Study

Understanding hepatitis E vaccination intention among women of childbearing-age: A theory-based cross-sectional study

Beyond the needle: a qualitative exploration of Sierra Leonean healthcare workers' post COVID-19 vaccination experiences

A Phase 1, Double-blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin®) Vaccine in Healthy US Adults

Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy

Hepatitis E Vaccines: A Mini Review

Perceptions, attitudes, and willingness of healthcare and frontline workers to participate in an Ebola vaccine trial in Uganda